Eiger BioPharmaceuticals Investor Relations Material
Latest events
Status Update
Eiger BioPharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Eiger BioPharmaceuticals Inc
Access all reports
Eiger BioPharmaceuticals, Inc. (EIGR), a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Eiger's most advanced pipeline product candidate is Zileuton XL, which is an oral prodrug of zileuton that is being developed for the treatment of eosinophilic airway diseases (EAD).
Key slides for Eiger BioPharmaceuticals Inc
Status Update
Eiger BioPharmaceuticals Inc
Status Update
Eiger BioPharmaceuticals Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States